Concepedia

Publication | Open Access

A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma

DOIFull Paper Access

50

Citations

13

References

2021

Year

Dave Singh, Rainard Fuhr, Nicholas Bird, Sarah Mole, Kelly Hardes, Yau Lun Man, Anthony Cahn, Steven W. Yancey, Isabelle Pouliquen
British Journal of Clinical Pharmacology

Abstract

GSK3511294 was well tolerated, with linear and dose proportional PK, extended half-life and blood eosinophil count reduction, supporting less frequent dosing versus other anti-IL-5 mAbs.

References

YearCitations

Page 1